Hirschberg, Germany

Matthias Scheffler

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.7

ph-index = 1


Location History:

  • Hirschberg-Leutershausen, DE (2017)
  • Hirschberg, DE (2019)
  • Heidelberg, DE (2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Matthias Scheffler

Introduction

Matthias Scheffler, an inventor based in Hirschberg, Germany, has made significant strides in the field of medical diagnostics. With three patents to his name, his work focuses on the use of miRNAs as biomarkers for various medical conditions, highlighting his commitment to improving patient care through innovative research.

Latest Patents

Among Matthias Scheffler’s latest inventions are two groundbreaking patents that address critical health issues. The first patent, "MiRNAs as non-invasive biomarkers for inflammatory bowel disease," presents a method for diagnosing Inflammatory Bowel Disease (IBD) by determining the expression profiles of miRNAs. This invention includes a diagnostic kit that allows for the identification of IBD through non-invasive means. The second patent, "MiRNA based treatment monitoring in multiple sclerosis," outlines methods to determine how patients respond to therapeutic treatments for multiple sclerosis (MS). This innovative patent not only monitors the progression of MS but also assists in adjusting treatment doses based on miRNA levels, thereby offering tailored medical care.

Career Highlights

Matthias Scheffler currently works at Hummingbird Diagnostics GmbH, where he applies his knowledge and skills to advance the field of diagnostics. His contributions have not gone unnoticed, as he has built a reputation for himself through the development of his patented inventions, which have the potential to impact patient treatment significantly.

Collaborations

At Hummingbird Diagnostics GmbH, Matthias collaborates with talented individuals like Andreas Keller and Markus Beier. Together, they work to push the boundaries of medical science and enhance diagnostic processes for challenging conditions like IBD and MS.

Conclusion

Through his innovative patents and collaboration with skilled professionals, Matthias Scheffler is making a meaningful impact in the medical field. His work on miRNAs as biomarkers demonstrates the potential for significant advancements in diagnostics, paving the way for improved patient outcomes in inflammatory bowel disease and multiple sclerosis. With a firm commitment to medical innovation, Scheffler’s contributions are poised to inspire future developments in health technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…